Applications now open:

Vaccinology in Africa 2019 Master’s Level Course

Applications are now open for the next Vaccinology in Africa Course, 29th April – 3rd May 2019, at the MRC Unit in Banjul, The Gambia. 
The course is specifically aimed at students, researchers and professionals resident in Africa and cover the main aspects of vaccinology, the vaccine development process, biomanufacturing, regulatory and ethical issues.
The course has an exceptional faculty of academic and industrial speakers, and resonates with the ‘One Health’ agenda by highlighting human and veterinary links and synergies between the two fields from scientific, technological and regulatory perspectives. Participants are selected on the basis of their direct involvement with vaccine development, and their excellence in professional and academic achievement. The course are fully funded for successful applicants and covers air travel within the African region, accommodation and meals. 
The 2019 course is open to residents of the following countries: Algeria, Benin, Burkina Faso, Cameroon, Central African Republic, Congo, Côte d'Ivoire, Equatorial Guinea, Gabon, Ghana, Guinea, Guinea Bissau, Liberia, Mali, Mauritania, Morocco, Niger, Nigeria, Senegal, Sierra Leone, Tchad, The Gambia, Togo, Tunisia, Western Sahara.  
The course alternates between African regions and previous courses have been held at the Noguchi Memorial Institute for Medical Research in Accra, Ghana (2013), at the International Livestock Research Institute in Nairobi, Kenya (2014), the Malaria Research and Training Centre & Centre d’Infectiologie Charles Mérieux in Bamako, Mali (2015) and the Makerere University/ UVRI Centre of Excellence in Infection and Immunity Research and Training in Entebbe, Uganda (2017).
Applications for this course are now closed. New courses will be advertised here as soon as the dates are confirmed.
Draft Programme:

Day 1: Principles of Vaccinology

Day 2: Vaccine technologies & their development

Day 3: Major Vaccine Targets

Day 4: Vaccine Development and Clinical Trials 

Day 5: Vaccine Development in Developing Countries

Confirmed speakers:

Adrian Hill, Jenner Institute, University of Oxford

Allan Saul, GSK Vaccines Institute for Global Health

Amadou Sall, Institut Pasteur, Dakar

Andrew Pollard, Oxford Vaccine Group, University of Oxford

Andrew Prentice, MRC Unit The Gambia

Baptiste Dungu, MCI Santé Animale, Morocco

Beate Kampmann, MRC Unit The Gambia

Bryan Charleston, Pirbright Institute

Carla Cerami, MRC Unit The Gambia

Chris Netherton, Pirbright Institute

Ed Clark, MRC Unit The Gambia

Frédéric Tangy, Institut Pasteur, Paris

Helen Fletcher, London School of Hygiene & Tropical Medicine

Jayne Sutherland, MRC Unit The Gambia

Kwaku Poku Asante, Kintampo Health Research Centre, Ghana

Sarah Gilbert, Jenner Institute, University of Oxford

Umberto d'Alessandro, MRC Unit The Gambia

Vish Nene, ILRI, Nairobi